Response to immunotherapy in six related horses with urticaria secondary to atopy.
- Case Reports
- Journal Article
Summary
This research article suggests that immunotherapy, specifically involving a specialized vaccine, could be a potential treatment strategy for horses afflicted with urticaria – a condition related to an allergic reaction, that’s suspected to be inheritable in certain horse families.
Context and Problem
Urticaria is a condition that presents in horses as hives due to an allergic reaction, specifically a condition known as atopy – which involves an overreaction by the immune system to common substances in the environment like dust or pollen. In certain horse families, it has been observed that this may be a genetic or familial issue. This presents a challenge in treatment, making it necessary to explore novel approaches.
Approach
The study explored the use of immunotherapy as a means of treating this condition in horses. Immunotherapy refers to stimulating the body’s own immune system to work smarter or harder to attack certain diseases.
- The researchers developed a specialized vaccine, created using antigens. Antigens are substances in the body that prompt an immune response.
- The antigens for this particular vaccine were carefully chosen based on the horse’s medical history and results from intradermal testing (a skin test to check for allergies).
Key Findings
This immunotherapy strategy proved effective in managing atopy in horses with urticaria.
- A positive response to the therapy was noticed within two months, indicating the potential quick effectiveness of this approach.
- This presents an appealing alternative to treating familial urticaria in horses, especially considering the challenges presented by hereditary conditions.
Implications
This research brings hope for a more effective management plan for horses struggling with familial urticaria. Importance lies in the potential quick response time to the therapy, combined with the precision nature of the vaccine, customized to an individual horse’s antigen profile. It also broadens overall understanding of treating allergic conditions, adding to the scientific conversation around novel therapeutic strategies for hereditary conditions. Future work could possibly investigate long-term effects of such an approach, or explore how this may be applied across different species or related conditions.
Cite This Article
Publication
Researcher Affiliations
- Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, Texas A&M University, College Station 77843-4474, USA.
MeSH Terms
- Animals
- Female
- Horse Diseases / etiology
- Horse Diseases / immunology
- Horse Diseases / therapy
- Horses
- Hypersensitivity, Immediate / complications
- Hypersensitivity, Immediate / immunology
- Hypersensitivity, Immediate / veterinary
- Immunotherapy / veterinary
- Intradermal Tests / veterinary
- Male
- Urticaria / etiology
- Urticaria / immunology
- Urticaria / therapy
- Urticaria / veterinary
Citations
This article has been cited 3 times.- Herrmann I, Sanchez AJ. Efficacy and Safety of Subcutaneous Allergen-Specific Immuno-Therapy in Horses with Allergic Cutaneous and Respiratory Diseases-A Systematic Review. Vet Sci 2023 Oct 10;10(10).
- Wobeser BK. Anthrax vaccine associated deaths in miniature horses. Can Vet J 2015 Apr;56(4):359-60.
- O Morris D, Lindborg S. Determination of 'irritant' threshold concentrations for intradermal testing with allergenic insect extracts in normal horses. Vet Dermatol 2003 Feb;14(1):31-36.